Alpha-Mangostin ameliorates acute kidney injury via modifying levels of circulating TNF-α and IL-6 in glycerol-induced rhabdomyolysis animal model

Acta Biochim Pol. 2023 Apr 17;70(2):277-284. doi: 10.18388/abp.2020_6509.

Abstract

Alpha mangostin (AM), isolated from G. mangostana, showed beneficial effects in several disorders due to its antioxidant and anti-inflammatory properties. Acute kidney injury (AKI) due to different etiologies can develop into severe complications, resulting in high mortality rates. In this work, AM is tested for its ability to alleviate AKI in glycerol-induced AKI rat model, where 30 Male Sprague-Dawley rats were assigned to a healthy group, glycerol-treated group and AM-treated group. Glycerol- and AM groups received a single dose of glycerol (per IM, 50% glycerol in saline, 8 ml/kg), whereas control group was injected with saline. AM treatment (a single daily dose, per IP, 175mg/kg) was accomplished for three days. Animals were executed to collect blood samples and kidney tissue for biochemical and histological examination. It was found that glycerol induced increase in serum creatinine, blood urea nitrogen (BUN), lipid peroxidation, serum magnesium, TNF-α and IL-6. It also induced renal edema and hypocalcemia along with histopathological renal damage. AM treatment improved renal histological features and alleviated increase in serum creatinine, BUN, serum magnesium, TNF-α and IL-6 levels, as well as renal edema and lipid peroxidation but did not affect serum calcium levels. This suggests AM as a potential therapeutic agent for treating AKI mainly via its antioxidant and anti-inflammatory properties.

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / drug therapy
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Creatinine / adverse effects
  • Glycerol / pharmacology
  • Interleukin-6
  • Kidney
  • Magnesium / therapeutic use
  • Male
  • Models, Animal
  • Rats
  • Rats, Sprague-Dawley
  • Rhabdomyolysis* / chemically induced
  • Rhabdomyolysis* / complications
  • Rhabdomyolysis* / drug therapy
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • mangostin
  • Tumor Necrosis Factor-alpha
  • Antioxidants
  • Glycerol
  • Interleukin-6
  • Creatinine
  • Magnesium
  • Anti-Inflammatory Agents